We are live on ! Find out more
SCS

Syquant Capital SAS Portfolio holdings

AUM $447M
1-Year Est. Return 13.04%
This Fund
S&P 500
This Quarter Est. Return
-6.54%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
AUM
$407M
AUM Growth
+$213M
Cap. Flow
+$238M
Cap. Flow %
58.46%
Top 10 Hldgs %
98.84%
Holding
27
New
11
Increased
5
Reduced
2
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 47.02%
2 Technology 13.88%
3 Consumer Discretionary 11.28%
4 Energy 4.21%
5 Industrials 2.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$191M 47.02%
1,080,922
+1,025,422
+1,848% +$193M
TIF
2
DELISTED
Tiffany & Co.
TIF
$74.8M 18.38%
577,813
+567,013
+5,250% +$74.6M
WBC
3
DELISTED
WABCO HOLDINGS INC.
WBC
$44.9M 11.04%
+332,807
New +$44.8M
TECD
4
DELISTED
Tech Data Corp
TECD
$38.2M 9.38%
291,897
+189,142
+184% +$26.2M
TGE
5
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$17.2M 4.21%
1,042,040
+69,591
+7% +$1.42M
CY
6
DELISTED
Cypress Semiconductor
CY
$14.4M 3.54%
618,016
-164,484
-21% -$3.76M
OMN
7
DELISTED
OMNOVA Solutions Inc.
OMN
$7.39M 1.81%
728,557
+302,300
+71% +$3.01M
EE
8
DELISTED
El Paso Electric Company
EE
$6.67M 1.64%
+98,163
New +$6.65M
RTX icon
9
RTX Corp
RTX
$262B
$3.73M 0.92%
+62,766
New +$5.31M
LOGM
10
DELISTED
LogMein, Inc.
LOGM
$3.67M 0.9%
+44,093
New +$3.72M
BMY.RT
11
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.41M 0.35%
370,621
-281,865
-43% -$929K
HHH icon
12
Howard Hughes
HHH
$4.3B
$1.26M 0.31%
+26,225
New +$2.63M
YETI icon
13
Yeti Holdings
YETI
$3.87B
$976K 0.24%
+50,000
New +$1.48M
GO icon
14
Grocery Outlet
GO
$948M
$402K 0.1%
+11,708
New +$381K
DT icon
15
Dynatrace
DT
$13B
$238K 0.06%
+10,000
New +$288K
CCXX.U
16
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
$200K 0.05%
+20,000
New +$204K
FEAC.U
17
DELISTED
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
$150K 0.04%
+15,000
New +$150K
DMYT.U
18
DELISTED
dMY Technology Group, Inc. Units, each consisting of one share of Class A Common Stock and one-half
DMYT.U
$98K 0.02%
+10,000
New +$100K
DBVT
19
DBV Technologies
DBVT
$880M
-43,000
Closed -$4.6M
RARX
20
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-129,690
Closed -$6.09M
DPLO
21
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-94,260
Closed -$377K
TOO
22
DELISTED
Teekay Offshore Partners L.P.
TOO
-3,047,400
Closed -$4.69M
ARQL
23
DELISTED
Arqule Inc
ARQL
-619,800
Closed -$12.4M
BOLD
24
DELISTED
Audentes Therapeutics, Inc
BOLD
-767,502
Closed -$45.9M
WAIR
25
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
-360,992
Closed -$3.98M

Similar funds

Syquant Capital SAS's Q1 2020 Portfolio in Review

As of Q1 2020, Syquant Capital SAS held 27 positions worth $407M, up 110% from $194M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Syquant Capital SAS deployed $238M of net new capital in Q1 2020, opening 11 new positions and adding to 5 existing holdings. Its largest new stake was WABCO HOLDINGS INC.: 332,807 shares worth $44.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 41% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cypress Semiconductor, an estimated $3.76M trimmed.

  • Syquant Capital SAS's largest Q1 2020 buy was WABCO HOLDINGS INC.: 332,807 shares worth $44.9M.
  • Syquant Capital SAS added most to Allergan plc in Q1 2020, an estimated $193M increase.
  • Syquant Capital SAS's biggest Q1 2020 reduction was Cypress Semiconductor, cutting an estimated $3.76M.
  • Syquant Capital SAS fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $45.9M.
  • Syquant Capital SAS's ten largest holdings make up 99% of its $407M portfolio in Q1 2020.
  • Syquant Capital SAS opened 11 new positions and closed 9 in Q1 2020.
  • Syquant Capital SAS's portfolio value rose 110% quarter-over-quarter to $407M.

Based on Syquant Capital SAS's 13F filing for Q1 2020, filed 14 Apr 2020.